Terms: = Liver cancer AND CALCB, Calcitonin
234 results:
1. Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe.
Chondrogianni ME; Kyrou I; Androutsakos T; Flessa CM; Menenakos E; Chatha KK; Aranan Y; Papavassiliou AG; Kassi E; Randeva HS
Front Endocrinol (Lausanne); 2024; 15():1344376. PubMed ID: 38524631
[TBL] [Abstract] [Full Text] [Related]
2. liver Mass as First-Time Diagnosis of Sarcomatoid Anaplastic Thyroid Carcinoma: A Rare Malignancy Presenting at an Unexpected Body Site.
Kamashki A; Rivera M; Sturgis CD
Am J Case Rep; 2023 Dec; 24():e941838. PubMed ID: 38041397
[TBL] [Abstract] [Full Text] [Related]
3. Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: a case report.
Behdadnia A; Jeddi M
J Med Case Rep; 2023 Sep; 17(1):400. PubMed ID: 37670372
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
[TBL] [Abstract] [Full Text] [Related]
5. Adenosquamous carcinoma of the gallbladder simultaneously producing granulocyte-colony-stimulating factor and parathyroid hormone-related protein.
Yanagi M; Suda T; Oishi N; Kobayashi M; Matsushita E
Clin J Gastroenterol; 2023 Dec; 16(6):901-907. PubMed ID: 37598132
[TBL] [Abstract] [Full Text] [Related]
6. Tumor-to-Tumor Metastasis of Medullary Thyroid Carcinoma to Paraganglioma in a Multiple Endocrine Neoplasia Type 2B Patient: A Case Report and Literature Review.
Takido N; Saito R; Okada K; Kanai N; Shono Y; Mitsugashira H; Matsumura M; Sasaki K; Miyazawa K; Fujio A; Tokodai K; Murakami K; Sasano H; Unno M; Ishida T; Kamei T
Tohoku J Exp Med; 2023 Sep; 261(1):75-81. PubMed ID: 37468258
[TBL] [Abstract] [Full Text] [Related]
7. Thirty synchronous medullary and papillary thyroid carcinomas.
Zhang D; Yang M; Zhang X; Wang C; Li K; Wang H; Chi H; Sui C; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1153248. PubMed ID: 37065753
[TBL] [Abstract] [Full Text] [Related]
8. Expression profile of adrenomedullin and its specific receptors in liver tissues from patients with hepatocellular carcinoma and in tumorigenic cell line-secreted extracellular vesicles.
Cabiati M; Gaggini M; De Simone P; Salvadori C; Del Turco S; Caselli C; Cecchettini A; Del Ry S
Pathol Res Pract; 2023 Mar; 243():154383. PubMed ID: 36827885
[TBL] [Abstract] [Full Text] [Related]
9. Intermedin (adrenomedullin 2) promotes breast cancer metastasis via Src/c-Myc-mediated ribosome production and protein translation.
Kong L; Xiong Y; Wang D; Huang L; Li M; Feng Z; Zhou Y; Zhang H; Liu F; Xiao F; Wei Y; Zhang W
Breast Cancer Res Treat; 2022 Sep; 195(2):91-103. PubMed ID: 35896852
[TBL] [Abstract] [Full Text] [Related]
10. Prospective study on the clinical relevance of
Califano I; Pitoia F; Chirico R; De Salazar A; Bastianello MJ
Endocrine; 2022 Jun; 77(1):143-150. PubMed ID: 35489000
[TBL] [Abstract] [Full Text] [Related]
11. Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives.
Klain M; Hadoux J; Nappi C; Finessi M; Ambrosio R; Schlumberger M; Cuocolo A; Deandreis D; Salvatore D
Endocrine; 2022 Feb; 75(2):330-337. PubMed ID: 34748168
[TBL] [Abstract] [Full Text] [Related]
12. Metastatic Medullary Thyroid cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy.
Hayes AR; Crawford A; Al Riyami K; Tang C; Bomanji J; Baldeweg SE; Wild D; Morganstein D; Harry A; Grozinsky-Glasberg S; Oleinikov K; Khoo B; Caplin ME; Nicolas GP; Grossman AB
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4903-e4916. PubMed ID: 34379772
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT.
Asa S; Sonmezoglu K; Uslu-Besli L; Sahin OE; Karayel E; Pehlivanoglu H; Sager S; Kabasakal L; Ocak M; Sayman HB
Ann Nucl Med; 2021 Aug; 35(8):900-915. PubMed ID: 33993425
[TBL] [Abstract] [Full Text] [Related]
14. Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
Johnson K; Issa M; Parikh A; Monk P; Yin M; Mortazavi A; Yang Y
BMC Urol; 2021 Apr; 21(1):51. PubMed ID: 33794867
[TBL] [Abstract] [Full Text] [Related]
15. Intermedin facilitates hepatocellular carcinoma cell survival and invasion via ERK1/2-EGR1/DDIT3 signaling cascade.
Xiao F; Li H; Feng Z; Huang L; Kong L; Li M; Wang D; Liu F; Zhu Z; Wei Y; Zhang W
Sci Rep; 2021 Jan; 11(1):488. PubMed ID: 33436794
[TBL] [Abstract] [Full Text] [Related]
16. The role of
Şahin OE; Uslu-Beşli L; Asa S; Sağer S; Sönmezoğlu K
Hell J Nucl Med; 2020; 23(3):321-329. PubMed ID: 33367304
[TBL] [Abstract] [Full Text] [Related]
17. Inhibition of Intermedin (Adrenomedullin 2) Suppresses the Growth of Glioblastoma and Increases the Antitumor Activity of Temozolomide.
Huang L; Wang D; Feng Z; Zhao H; Xiao F; Wei Y; Zhang H; Li H; Kong L; Li M; Liu F; Zhang H; Zhang W
Mol Cancer Ther; 2021 Feb; 20(2):284-295. PubMed ID: 33298587
[TBL] [Abstract] [Full Text] [Related]
18. Breast metastasis from medullary thyroid carcinoma mimicking ductal carcinoma with neuroendocrine differentiation.
Laforga JB; Dominguez E; Aranda FI
Cancer Rep (Hoboken); 2020 Dec; 3(6):e1292. PubMed ID: 33025739
[TBL] [Abstract] [Full Text] [Related]
19. The Neuropeptide System and Colorectal cancer liver Metastases: Mechanisms and Management.
Kasprzak A; Adamek A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429087
[TBL] [Abstract] [Full Text] [Related]
20. Neuroendocrine tumor with diarrhea: not always the usual suspects - a case report of metastatic calcitoninoma with literature review.
Vlaemynck K; De Man M; De Man K; Hoorens A; Geboes K
Acta Clin Belg; 2021 Jun; 76(3):239-243. PubMed ID: 31900071
[TBL] [Abstract] [Full Text] [Related]
[Next]
